TOWER Life sale rumours increase
Good Returns first reported that Fidelity was looking at TOWER last year.
It would be a revenge of sorts for Fidelity, which received a hostile takeover offer from Tower in 2010. The failed bid valued Fidelity at $118 million, equating to $82 per share. Since then, its share price has remained above $90 and now sits at $95.
Rumours have been rife that TOWER was on the cusp of selling more of its assets since it sold its medical insurance business to Australian firm nib in November for $100 million.
TOWER interim chairman Stephen Smith said in its most recent annual report that the group was looking at the options.
Click the button below to subscribe and will have free unlimited access for a limited time to full article and all other articles on the site.
You will also be able to comment on articles on Good Returns.